' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | BIMZELX (bimekizumab) is approved for five different patient populations spanning dermatology and rheumatology. Discover the three indications for BIMZELX in dermatology – PSO and HS. BIMZELX is approved also for two indications in rheumatology – PSA and axSpA. |
h1 tags | Your page doesn't have H1 tags. |
h2 tags | Welcome to the BIMZELX®▼ (bimekizumab) European website for healthcare professionals You are here |
Site Speed | 0.17692303657532 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| www.bimzelx.eu | HINFO | IN | 300 |